Nevertheless, even in the short window of exposure to these compounds, the selective COX-2 inhibitors produced significant reductions in the risk of colon cancer, underscoring their strong potential for colon cancer chemoprevention. The gene discussed is PTGS2; the disease is colonic neoplasm.